Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity
2014 · Nature Communications · 603 citations
https://doi.org/10.1038/ncomms5277
B
Boris Klebanov
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
111
Papers
2.5K
Citations
21
h-index
24
i10-index
Boris Klebanov is an academic researcher. The author has contributed to research in topics: Nuclear Structure and Function & Immunotherapy and Immune Responses & Cancer-related Molecular Pathways. The author has an h-index of 21, co-authored 95 publications.
ORCID: 0000-0002-6969-6582Papers by this author
worksSystemic RNAi-mediated Gene Silencing in Nonhuman Primate and Rodent Myeloid Cells
2012 · Molecular Therapy — Nucleic Acids · 135 citations
https://doi.org/10.1038/mtna.2011.3
Deciphering mechanisms of drug sensitivity and resistance to Selective Inhibitor of Nuclear Export (SINE) compounds
2015 · BMC Cancer · 27 citations
https://doi.org/10.1186/s12885-015-1790-z
Additional file 1: Table S1. of Deciphering mechanisms of drug sensitivity and resistance to Selective Inhibitor of Nuclear Export (SINE) compounds
2015 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.c.3643532_d1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat